We are analyzing https://link.springer.com/article/10.1186/s13024-016-0094-3.

Title:
MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease | Molecular Neurodegeneration
Description:
Background α-Synuclein (α-Syn), a pathological hallmark of Parkinson’s disease (PD), has been recognized to induce the production of interleukin-1β in a process that depends, at least in vitro, on nod-like receptor protein 3 (NLRP3) inflammasome in monocytes. However, the role of NLRP3 inflammasome activation in the onset of PD has not yet been fully established. Results In this study, we showed that NLRP3 inflammasomes were activated in the serum of PD patients and the midbrain of PD model mice. We further clarified that α-syn activated the NLRP3 inflammasome through microglial endocytosis and subsequent lysosomal cathepsin B release. Deficiency of caspase-1, an important component of NLRP3 inflammasome, significantly inhibited α-syn-induced microglia activation and interleukin-1β production, which in turn alleviated the reduction of mesencephalic dopaminergic neurons treated by microglia medium. Specifically, we demonstrated for the first time that Nlrp3 is a target gene of microRNA-7 (miR-7). Transfection of miR-7 inhibited microglial NLRP3 inflammasome activation whereas anti-miR-7 aggravated inflammasome activation in vitro. Notably, stereotactical injection of miR-7 mimics into mouse striatum attenuated dopaminergic neuron degeneration accompanied by the amelioration of microglial activation in MPTP-induced PD model mice. Conclusions Our study provides a direct link between miR-7 and NLRP3 inflammasome-mediated neuroinflammation in the pathogenesis of PD. These findings will give us an insight into the potential of miR-7 and NLRP3 inflammasome in terms of opening up novel therapeutic avenues for PD.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

nlrp, αsyn, inflammasome, activation, cells, mice, pubmed, caspase, ilβ, article, fig, data, google, scholar, microglial, expression, presented, sem, microglia, experiments, cas, disease, independent, pathogenesis, production, neurons, neuroinflammation, model, mimics, parkinsons, role, midbrain, protein, inflammasomes, αsynuclein, results, effect, additional, group, patients, cell, control, central, serum, αsyninduced, treated, antimir, mouse, mptp, human,

Topics {✒️}

5-amino-1-β-d-ribofuranosyl-imidazole-4-carboxamide cm 5-amino-1-β-d-ribofuranosyl-imidazole-4-carboxamide benzyloxycarbonyl–tyr-val-ala-asn–fluoromethylketone stem-loop primer sequence α-syn-induced cascade activation caspase-1-specific inhibitor z-yvad-fmk α-syn-induced microglial inflammation α-syn activates nf-κb α-syn-induced microglial activation α-syn-induced inflammasome activation inactive precursor pro-il-1β a53t α-syn-induced upregulation abolish α-syn-induced activation α-syn-induced caspase-1 activation 20 mg/kg mptp dissolved α-synuclein-triggered neuroinflammation plays nlrp3/caspase-1/il-1β axis α-synuclein-induced lysosomal damage 6-methyl-phenyl-tetrahydropyridine/probenecid msu goat anti-il-1 β microglial activation-mediated delayed r-luc-nlrp3-3′-utr reporter α-syn-evoked neuroinflammation article download pdf ke-zhong zhang α-syn-ir cells accumulation α-syn-induced activation a53t α-syn induced dopaminergic olfactory-striatal interplay nlrp3 inflammasome-mediated neuroinflammation reduces il-1β production reagents α-syn-a53t 6-methyl-phenyl-tetrahydropyridine/probenecid α-syn treatment group adipose-tissue-infiltrating macrophages α-syn-treated bv2 cells fitc-labeled α-syn α-syn-overexpressed mice wide-type α-syn increased α-syn accumulation selected monomeric α-synuclein microglial il-1β generation inhibits il-1β production mir-7 targets α-syn il-1beta increases susceptibility anti-α-syn protein α-syn a53t human a53t α-syn human central nervous system a53t mutant α-syn

Questions {❓}

The NLRP3 inflammasome: a sensor for metabolic danger?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease
         description:α-Synuclein (α-Syn), a pathological hallmark of Parkinson’s disease (PD), has been recognized to induce the production of interleukin-1β in a process that depends, at least in vitro, on nod-like receptor protein 3 (NLRP3) inflammasome in monocytes. However, the role of NLRP3 inflammasome activation in the onset of PD has not yet been fully established. In this study, we showed that NLRP3 inflammasomes were activated in the serum of PD patients and the midbrain of PD model mice. We further clarified that α-syn activated the NLRP3 inflammasome through microglial endocytosis and subsequent lysosomal cathepsin B release. Deficiency of caspase-1, an important component of NLRP3 inflammasome, significantly inhibited α-syn-induced microglia activation and interleukin-1β production, which in turn alleviated the reduction of mesencephalic dopaminergic neurons treated by microglia medium. Specifically, we demonstrated for the first time that Nlrp3 is a target gene of microRNA-7 (miR-7). Transfection of miR-7 inhibited microglial NLRP3 inflammasome activation whereas anti-miR-7 aggravated inflammasome activation in vitro. Notably, stereotactical injection of miR-7 mimics into mouse striatum attenuated dopaminergic neuron degeneration accompanied by the amelioration of microglial activation in MPTP-induced PD model mice. Our study provides a direct link between miR-7 and NLRP3 inflammasome-mediated neuroinflammation in the pathogenesis of PD. These findings will give us an insight into the potential of miR-7 and NLRP3 inflammasome in terms of opening up novel therapeutic avenues for PD.
         datePublished:2016-04-16T00:00:00Z
         dateModified:2016-04-16T00:00:00Z
         pageStart:1
         pageEnd:15
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13024-016-0094-3
         keywords:
            microRNA-7
            NLRP3 inflammasome
            α-Synuclein
            Neuroinflammation
            Parkinson’s disease
            Neurosciences
            Neurology
            Molecular Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13024-016-0094-3/MediaObjects/13024_2016_94_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13024-016-0094-3/MediaObjects/13024_2016_94_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13024-016-0094-3/MediaObjects/13024_2016_94_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13024-016-0094-3/MediaObjects/13024_2016_94_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13024-016-0094-3/MediaObjects/13024_2016_94_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13024-016-0094-3/MediaObjects/13024_2016_94_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13024-016-0094-3/MediaObjects/13024_2016_94_Fig7_HTML.gif
         isPartOf:
            name:Molecular Neurodegeneration
            issn:
               1750-1326
            volumeNumber:11
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yan Zhou
               affiliation:
                     name:Nanjing Medical University
                     address:
                        name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ming Lu
               affiliation:
                     name:Nanjing Medical University
                     address:
                        name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ren-Hong Du
               affiliation:
                     name:Nanjing Medical University
                     address:
                        name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chen Qiao
               affiliation:
                     name:Nanjing Medical University
                     address:
                        name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chun-Yi Jiang
               affiliation:
                     name:Nanjing Medical University
                     address:
                        name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ke-Zhong Zhang
               affiliation:
                     name:Nanjing Medical University Hospital
                     address:
                        name:Nanjing Medical University Hospital, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jian-Hua Ding
               affiliation:
                     name:Nanjing Medical University
                     address:
                        name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gang Hu
               affiliation:
                     name:Nanjing Medical University
                     address:
                        name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
                        type:PostalAddress
                     type:Organization
                     name:Nanjing Normal University
                     address:
                        name:Biomedical Functional Materials Collaborative Innovation Center, College of Chemistry and Materials Science, Nanjing Normal University, Nanjing, China
                        type:PostalAddress
                     type:Organization
                     name:Nanjing University of Chinese Medicine
                     address:
                        name:Department of Pharmacology, Nanjing University of Chinese Medicine, Nanjing, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease
      description:α-Synuclein (α-Syn), a pathological hallmark of Parkinson’s disease (PD), has been recognized to induce the production of interleukin-1β in a process that depends, at least in vitro, on nod-like receptor protein 3 (NLRP3) inflammasome in monocytes. However, the role of NLRP3 inflammasome activation in the onset of PD has not yet been fully established. In this study, we showed that NLRP3 inflammasomes were activated in the serum of PD patients and the midbrain of PD model mice. We further clarified that α-syn activated the NLRP3 inflammasome through microglial endocytosis and subsequent lysosomal cathepsin B release. Deficiency of caspase-1, an important component of NLRP3 inflammasome, significantly inhibited α-syn-induced microglia activation and interleukin-1β production, which in turn alleviated the reduction of mesencephalic dopaminergic neurons treated by microglia medium. Specifically, we demonstrated for the first time that Nlrp3 is a target gene of microRNA-7 (miR-7). Transfection of miR-7 inhibited microglial NLRP3 inflammasome activation whereas anti-miR-7 aggravated inflammasome activation in vitro. Notably, stereotactical injection of miR-7 mimics into mouse striatum attenuated dopaminergic neuron degeneration accompanied by the amelioration of microglial activation in MPTP-induced PD model mice. Our study provides a direct link between miR-7 and NLRP3 inflammasome-mediated neuroinflammation in the pathogenesis of PD. These findings will give us an insight into the potential of miR-7 and NLRP3 inflammasome in terms of opening up novel therapeutic avenues for PD.
      datePublished:2016-04-16T00:00:00Z
      dateModified:2016-04-16T00:00:00Z
      pageStart:1
      pageEnd:15
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13024-016-0094-3
      keywords:
         microRNA-7
         NLRP3 inflammasome
         α-Synuclein
         Neuroinflammation
         Parkinson’s disease
         Neurosciences
         Neurology
         Molecular Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13024-016-0094-3/MediaObjects/13024_2016_94_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13024-016-0094-3/MediaObjects/13024_2016_94_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13024-016-0094-3/MediaObjects/13024_2016_94_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13024-016-0094-3/MediaObjects/13024_2016_94_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13024-016-0094-3/MediaObjects/13024_2016_94_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13024-016-0094-3/MediaObjects/13024_2016_94_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13024-016-0094-3/MediaObjects/13024_2016_94_Fig7_HTML.gif
      isPartOf:
         name:Molecular Neurodegeneration
         issn:
            1750-1326
         volumeNumber:11
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yan Zhou
            affiliation:
                  name:Nanjing Medical University
                  address:
                     name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ming Lu
            affiliation:
                  name:Nanjing Medical University
                  address:
                     name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ren-Hong Du
            affiliation:
                  name:Nanjing Medical University
                  address:
                     name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chen Qiao
            affiliation:
                  name:Nanjing Medical University
                  address:
                     name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chun-Yi Jiang
            affiliation:
                  name:Nanjing Medical University
                  address:
                     name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ke-Zhong Zhang
            affiliation:
                  name:Nanjing Medical University Hospital
                  address:
                     name:Nanjing Medical University Hospital, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jian-Hua Ding
            affiliation:
                  name:Nanjing Medical University
                  address:
                     name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gang Hu
            affiliation:
                  name:Nanjing Medical University
                  address:
                     name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
                     type:PostalAddress
                  type:Organization
                  name:Nanjing Normal University
                  address:
                     name:Biomedical Functional Materials Collaborative Innovation Center, College of Chemistry and Materials Science, Nanjing Normal University, Nanjing, China
                     type:PostalAddress
                  type:Organization
                  name:Nanjing University of Chinese Medicine
                  address:
                     name:Department of Pharmacology, Nanjing University of Chinese Medicine, Nanjing, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Molecular Neurodegeneration
      issn:
         1750-1326
      volumeNumber:11
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Nanjing Medical University
      address:
         name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University
      address:
         name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University
      address:
         name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University
      address:
         name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University
      address:
         name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University Hospital
      address:
         name:Nanjing Medical University Hospital, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University
      address:
         name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
         type:PostalAddress
      name:Nanjing Medical University
      address:
         name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
         type:PostalAddress
      name:Nanjing Normal University
      address:
         name:Biomedical Functional Materials Collaborative Innovation Center, College of Chemistry and Materials Science, Nanjing Normal University, Nanjing, China
         type:PostalAddress
      name:Nanjing University of Chinese Medicine
      address:
         name:Department of Pharmacology, Nanjing University of Chinese Medicine, Nanjing, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yan Zhou
      affiliation:
            name:Nanjing Medical University
            address:
               name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Ming Lu
      affiliation:
            name:Nanjing Medical University
            address:
               name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Ren-Hong Du
      affiliation:
            name:Nanjing Medical University
            address:
               name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Chen Qiao
      affiliation:
            name:Nanjing Medical University
            address:
               name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Chun-Yi Jiang
      affiliation:
            name:Nanjing Medical University
            address:
               name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Ke-Zhong Zhang
      affiliation:
            name:Nanjing Medical University Hospital
            address:
               name:Nanjing Medical University Hospital, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Jian-Hua Ding
      affiliation:
            name:Nanjing Medical University
            address:
               name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
               type:PostalAddress
            type:Organization
      name:Gang Hu
      affiliation:
            name:Nanjing Medical University
            address:
               name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
               type:PostalAddress
            type:Organization
            name:Nanjing Normal University
            address:
               name:Biomedical Functional Materials Collaborative Innovation Center, College of Chemistry and Materials Science, Nanjing Normal University, Nanjing, China
               type:PostalAddress
            type:Organization
            name:Nanjing University of Chinese Medicine
            address:
               name:Department of Pharmacology, Nanjing University of Chinese Medicine, Nanjing, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
      name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
      name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
      name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
      name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
      name:Nanjing Medical University Hospital, Nanjing, China
      name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
      name:Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
      name:Biomedical Functional Materials Collaborative Innovation Center, College of Chemistry and Materials Science, Nanjing Normal University, Nanjing, China
      name:Department of Pharmacology, Nanjing University of Chinese Medicine, Nanjing, China

External Links {🔗}(159)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

5.12s.

LINK . SPRINGER . COM {}